To provide for the periodic issuance of up-to-date clinical guidance on addressing the health effects of per- and polyfluoroalkyl substances (PFAS), and for other purposes.
About This Bill
Committee
Latest Action · July 25, 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.